Our Products

Aranesp (darbepoetin alfa)

For the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.

Enbrel (etanercept)

For the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.

EPOGEN (epoetin alfa)

For the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.

Neulasta (pegfilgrastim)

For the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.

NEUPOGEN (filgrastim)

For the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.

Nplate (romiplostim)

For the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.

Prolla (denosumab)

For the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.

Sensipar (cinacalcet)

For the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.

Vectibix (panitumumab)

For the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.

XGEVA (denosumba)

For the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.